E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, real estate, Bitcoin & more
All-In with Chamath, Jason, Sacks & Friedberg
00:00
The Controversy of Biogen's Alzheimer's Drug Approval
This chapter explores the complex approval process of Biogen's Alzheimer's drug and the FDA's role in fostering a competitive market for innovative treatments. It examines the potential consequences of rapid drug approvals on healthcare costs and the balance between patient needs and the financial implications for the healthcare system.
Transcript
Play full episode
